Inventor · disambiguated record
Mike Leblanc
Also filed as: LEBLANC MIKE
3 granted patents·2 pending applications·35 citations·filing 2009–2016
71Inventor score
Technology areasA61P
Files withSADAR MARIANNE D2BRITISH COLUMBIA CANCER AGENCY1BRITISH COLUMBIA CANCER AGENCY BRANCH1UNIV BRITISH COLUMBIA1
Top patents by PatentIndex Score
5 records- 0193US8686050B2Diglycidic ether derivative therapeutics and methods for their useBRITISH COLUMBIA CANCER AGENCY·Filed 2013·Granted Apr 1, 2014·19 cites·14 claims
- 0289US9862667B2Diglycidic ether derivative therapeutics and methods for their useSADAR MARIANNE D·Filed 2009·Granted Jan 9, 2018·14 cites·45 claims
- 0375US9487479B2Small molecule inhibitors of N-terminus activation of the androgen receptorSADAR MARIANNE D·Filed 2009·Granted Nov 8, 2016·2 cites·54 claims
- 0451US2017121261A1Diglycidic ether derivative therapeutics and methods for their useBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2016·Application pending·0 cites
- 0545US2017239216A1Small molecule inhibitors of n-terminus activation of the androgen receptorUNIV BRITISH COLUMBIA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mike Leblanc files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →